Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Study Information
Alliance Study ID: CALGB-100001
NCT Study ID (ClinicalTrials.gov): NCT00028600
Disease or Cancer Type: Multiple Myeloma & Plasma Cell Disorders
Alliance Study Chair: Kenneth C. Anderson, MD
Status: COMPLETED
Study Description
RATIONALE: Peripheral blood stem cell transplant using stem cells from the patient or a donor may be able to replace immune cells that were destroyed by chemotherapy used to kill tumor cells. The donated stem cells may also help destroy any remaining cancer cells (graft-versus-tumor effect).
PURPOSE: This phase II trial is studying how well autologous peripheral stem cell transplant followed by donor peripheral stem cell transplant works in treating patients with multiple myeloma.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information